Protea Biosciences and InSphero AG Successful in Mass Spectrometry Imaging of 3D Microtissues
Protea Biosciences Group, Inc.,and InSphero AG jointly announced an update from their collaboration focused on mass spectrometry imaging of InSphero’s 3D InSight™ microtissues. In August 2014, Protea received microtissues from InSphero and hosted members of InSphero’s scientific team for onsite training on the handling and preparation of the microtissues. Protea has since developed workflows for processing the 3D microtissues for mass spectrometry imaging and direct analysis. In addition, Protea has generated data from 3D microtissues grown from the HCT-116 colon...
View full press release